Targeted integration of nucleic acids
A targeting, nuclease technology, applied in nucleic acid vectors, biochemical equipment and methods, microorganisms, etc., can solve the problems of unstable cell growth and/or product expression, laborious, time-consuming, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0064] 6. Preparation and use of TI host cells
[0065] 7. Product
[0066] 8. Exemplary non-limiting embodiments
[0067] 1. Definition
[0068] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. In case of ambiguity, this patent specification (including definitions) shall prevail. Preferred methods and materials are described below, although methods and materials similar or equivalent to those described herein can be used in the practice or testing of the presently disclosed subject matter. All publications, patent applications, patents, and other references mentioned herein are incorporated by reference in their entirety. The materials, methods, and examples disclosed herein are illustrative only and not intended to be limiting.
[0069] As used herein, the terms "comprises," "including," "has," "has," "may," "containing," and variations thereof are intended to be op...
example
[0559] The following examples are merely illustrative of the presently disclosed subject matter and should not be considered limiting in any way.
example 1
[0560] Example 1: Discovery of High Yield Targeted Integration Sites in CHO Host Cells for Clinical and Commercial Cell Line Development
[0561] This example describes a method for identifying loci with high yields of targeted integration in the CHO genome. Conventional cell line development (CLD) relies on the random integration (RI) of plasmids carrying a sequence of interest (SOI). The process is unpredictable and time-consuming. Therefore, considerable effort is required to identify high-yielding RI clones. Unlike conventional RI CLD, targeted integration (TI) CLD introduces a transgene with a defined copy number (usually 1-2 copies) at a predetermined "hotspot" in the CHO genome. Given the low copy number and pretested integration sites, TI cell lines should have superior stability compared to RI cell lines. Furthermore, since selectable markers are only used to select cells with appropriate TIs and not cells with high levels of transgene expression, less mutagenic ma...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


